Humana Inc. (NYSE:HUM) is Pzena Investment Management LLC’s 9th Largest Position

Pzena Investment Management LLC increased its holdings in Humana Inc. (NYSE:HUM) by 44.0% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 3,609,382 shares of the insurance provider’s stock after acquiring an additional 1,103,132 shares during the period. Humana makes up about 3.2% of Pzena Investment Management LLC’s holdings, making the stock its 9th largest holding. Pzena Investment Management LLC owned approximately 3.00% of Humana worth $915,736,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. FPC Investment Advisory Inc. purchased a new position in shares of Humana during the fourth quarter worth $27,000. Centricity Wealth Management LLC purchased a new position in shares of Humana during the fourth quarter worth $30,000. Ashton Thomas Securities LLC purchased a new position in shares of Humana during the third quarter worth $31,000. OFI Invest Asset Management purchased a new position in shares of Humana during the fourth quarter worth $33,000. Finally, Atwood & Palmer Inc. boosted its position in shares of Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after buying an additional 60 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Truist Financial raised their price target on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. Barclays lifted their target price on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Morgan Stanley decreased their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a report on Wednesday, February 12th. Finally, StockNews.com lowered Humana from a “buy” rating to a “hold” rating in a report on Wednesday, March 5th. Twenty investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $285.68.

Insider Transactions at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 0.32% of the company’s stock.

Humana Stock Down 3.2 %

HUM opened at $251.41 on Tuesday. The business’s 50-day simple moving average is $271.74 and its 200-day simple moving average is $282.37. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The stock has a market capitalization of $30.33 billion, a P/E ratio of 25.27, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Analysts anticipate that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.41%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s dividend payout ratio (DPR) is currently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.